These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21794073)

  • 1. Controlling cancer growth from within the blood coagulation mechanism.
    Zacharski LR
    J Thromb Haemost; 2011 Sep; 9(9):1804-6. PubMed ID: 21794073
    [No Abstract]   [Full Text] [Related]  

  • 2. Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.
    Kozlowski EO; Pavao MS; Borsig L
    J Thromb Haemost; 2011 Sep; 9(9):1807-15. PubMed ID: 21676168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dermatan sulfate derivatives on platelet surface P-selectin expression and protein C activity in blood of inflammatory bowel disease patients.
    Ji SL; Du HY; Chi YQ; Cui HF; Cao JC; Geng MY; Guan HS
    World J Gastroenterol; 2004 Dec; 10(23):3485-9. PubMed ID: 15526370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatan sulfate obtained from the Phallusia nigra marine organism is responsible for antioxidant activity and neuroprotection in the neuroblastoma-2A cell lineage.
    de Sousa GF; Palmero CY; de Souza-Menezes J; Araujo AK; Guimarães AG; de Barros CM
    Int J Biol Macromol; 2020 Dec; 164():1099-1111. PubMed ID: 32629049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY; Ji SL; Song HF; Ye QN; Cao JC
    Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates.
    Pavão MS
    An Acad Bras Cienc; 2002 Mar; 74(1):105-12. PubMed ID: 11960179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity.
    Pavão MS; Mourão PA; Mulloy B; Tollefsen DM
    J Biol Chem; 1995 Dec; 270(52):31027-36. PubMed ID: 8537360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatan sulfate as a potential antithrombotic drug.
    Pangrazzi J; Gianese F
    Haematologica; 1987; 72(5):459-64. PubMed ID: 3121470
    [No Abstract]   [Full Text] [Related]  

  • 10. Chondroitin ABC lyase digestion of an ascidian dermatan sulfate. Occurrence of unusual 6-O-sulfo-2-acetamido-2-deoxy-3-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-beta-D-galactose units.
    Mourão PA; Pavão MS; Mulloy B; Wait R
    Carbohydr Res; 1997 May; 300(4):315-21. PubMed ID: 9210298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sulfated dermatan sulfates from Ascidians. Structure versus anticoagulant activity of these glycosaminoglycans.
    Pavão MS; Aiello KR; Werneck CC; Silva LC; Valente AP; Mulloy B; Colwell NS; Tollefsen DM; Mourão PA
    J Biol Chem; 1998 Oct; 273(43):27848-57. PubMed ID: 9774395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers.
    Harenberg J; Jeschek M; Acker M; Malsch R; Huhle G; Heene DL
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):49-56. PubMed ID: 8845462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatan sulfate as a potential therapeutic agent.
    Linhardt RJ; Hileman RE
    Gen Pharmacol; 1995 May; 26(3):443-51. PubMed ID: 7789716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula.
    Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
    Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B
    J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional heterogeneity in dermatan sulfate preparations.
    Fareed J; Hoppensteadt D; Walenga JM; Ahsan A; Coyne E; Breddin HK
    Semin Thromb Hemost; 1991; 17 Suppl 2():174-80. PubMed ID: 1948088
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological function of unique sulfated glycosaminoglycans in primitive chordates.
    Karamanou K; Espinosa DCR; Fortuna-Costa A; Pavão MSG
    Glycoconj J; 2017 Jun; 34(3):277-283. PubMed ID: 27614617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant activity of dermatan polysulfates.
    Akiyama F; Seno N; Yoshida K
    Tohoku J Exp Med; 1982 Apr; 136(4):359-65. PubMed ID: 6808700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.